135 related articles for article (PubMed ID: 38156867)
1. Frequency and Prognostic Impact of Aberrant Antigens Expression among Egyptian Adult Acute Leukemia.
Kaheled O; Aref S; El Menshawy N; Aref M; Ayed M
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4301-4307. PubMed ID: 38156867
[TBL] [Abstract][Full Text] [Related]
2. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
3. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
4. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19.
Mizutani M; Miwa H; Takahashi T; Katoh K; Shikami M; Katayama N; Shiku H; Kita K
Int J Hematol; 1997 Dec; 66(4):479-91. PubMed ID: 9479874
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia.
Abdulateef NA; Ismail MM; Aljedani H
Asian Pac J Cancer Prev; 2014; 15(1):221-7. PubMed ID: 24528030
[TBL] [Abstract][Full Text] [Related]
6. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
[TBL] [Abstract][Full Text] [Related]
7. FLT3-ITD DNA and mRNA levels in AML do not correlate with CD7, CD33 and CD123 expression.
Soare DS; Radu E; Dumitru I; Popov VM; Bumbea H; Vlădăreanu AM
J Cell Mol Med; 2020 Jul; 24(13):7675-7679. PubMed ID: 32460405
[TBL] [Abstract][Full Text] [Related]
8. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
9. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
10. Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia.
El-Sissy AH; El-Mashari MA; Bassuni WY; El-Swaayed AF
J Egypt Natl Canc Inst; 2006 Sep; 18(3):244-9. PubMed ID: 17671534
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotype of acute leukemia and its clinical significance].
Zhu H; Niu T; Meng W; Xu C; Lei S
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):118-20. PubMed ID: 12599447
[TBL] [Abstract][Full Text] [Related]
12. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
13. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
[TBL] [Abstract][Full Text] [Related]
14. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
[TBL] [Abstract][Full Text] [Related]
15. Frequency and Aberrant CD Marker Profile of Acute Leukaemias.
Arshad MZ; Hassan MA; Bibi M; Hussain M; Alam M; Riaz MO
J Coll Physicians Surg Pak; 2024 May; 34(5):539-544. PubMed ID: 38720213
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of Heterogeneous Biological Characteristics and Prognosis-Related Factors in AL Patients with Mistranslation-Expressed Lymphoid and Myeloid-Related Antigen].
Ma J; He GM; Liu H; Gao XY; Zhu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1263-1268. PubMed ID: 30295236
[TBL] [Abstract][Full Text] [Related]
17. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
18. [Clinical Features and Prognosis of 227 cases of Acute Myeloid Leukemia with Cross-lineage Antigen Expression].
Fang F; Zhu P; Zhang Y; Lu XZ; Dong YJ; Sun YH; Wang LH; Bu DF; Cen XN; Wang MJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):990-7. PubMed ID: 27531762
[TBL] [Abstract][Full Text] [Related]
19. Correlation of FLT3 mutations with expression of CD7 in acute myeloid leukemia.
Baqai J; Crisan D
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):104-8. PubMed ID: 25679063
[TBL] [Abstract][Full Text] [Related]
20. [Four cases of CD7-positive acute myeloid leukemia].
Tomiyama J; Mitsuhashi S; Kudo H; Adachi Y
Rinsho Ketsueki; 1993 Jan; 34(1):57-62. PubMed ID: 8450609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
